×

Kraig Biocraft Laboratories Publishes new Spider Silk Comparative Analysis and Estimates Report on its Corporate Website

ANN ARBOR, Mich., June 07, 2016 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has published a new comparative analysis report featuring data related to the global positioning of the company’s recombinant spider silk fibers.

The report is available at www.KraigLabs.com/comparison

“Given the various novel spider silk production techniques, management is extremely excited about how Kraig’s technology stacks up in this space. Publishing this data is in line with our efforts to remain open and transparent as possible. Our goal has always been to do more than just develop innovative wonder fibers. The results of this report reinforce our beliefs that we can deliver an outstanding value proposition for our customers, as well,” stated COO Jon Rice.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc.